Page 24 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

responses during five hours following consumption of and smell profile. Biosensors (Basel). 2020;10(8):83.
a high‐ and a low‐fat dairy drink. Mol Nutr Food Res. doi: 10.3390/bios10080083
2019;63(20):e1900189.
138. Neerincx AH, Geurts BP, van Loon J, et al. Detection of
doi: 10.1002/mnfr.201900189
Staphylococcus aureus in cystic fibrosis patients using
132. Gorynski K. A critical review of solid-phase breath VOC profiles. J Breath Res. 2016;10(4):046014.
microextraction applied in drugs of abuse determinations
and potential applications for targeted doping testing. doi: 10.1088/1752-7155/10/4/046014
Trends Analyt Chem. 2019;112:135-146. 139. Altomare DF, Di Lena M, Porcelli F, et al. Exhaled volatile
doi: 10.1016/j.trac.2018.12.029 organic compounds identify patients with colorectal
cancer. Br J Surg. 2013;100(1):144-150.
133. Abraham MH, Ibrahim A, Acree WE Jr. Air to liver partition
coefficients for volatile organic compounds and blood to doi: 10.1002/bjs.8942
liver partition coefficients for volatile organic compounds 140. Waltman CG, Marcelissen TA, van Roermund JG.
and drugs. Eur J Med Chem. 2007;42(6):743-751. Exhaled-breath testing for prostate cancer based on
doi: 10.1016/j.ejmech.2006.12.011 volatile organic compound profiling using an electronic
nose device (Aeonose™): A preliminary report. Eur Urol
134. Łuczykowski K, Warmuzińska N, Bojko B. Solid phase Focus. 2020;6(6):1220-1225.
microextraction-a promising tool for graft quality
monitoring in solid organ transplantation. Separations. doi: 10.1016/j.euf.2018.11.006
2023;10(3):153. 141. Liu Q, Fan Y, Zeng S, et al. Volatile organic compounds
doi: 10.3390/separations10030153 for early detection of prostate cancer from urine. Heliyon.
2023;9(6):e16686.
135. Hüppe T, Klasen R, Maurer F, et al. Volatile organic
compounds in patients with acute kidney injury and doi: 10.1016/j.heliyon.2023.e16686
changes during dialysis. Crit Care Med. 2019;47(2):239-246. 142. Amal H, Leja M, Funka K, et al. Detection of precancerous
doi: 10.1097/CCM.0000000000003523 gastric lesions and gastric cancer through exhaled breath.
Gut. 2016;65(3):400-407.
136. Sethi S, Ranjan N, Trinad C. Clinical application of volatile
organic compound analysis for detecting infectious doi: 10.1136/gutjnl-2014-308536
diseases. Clin Microbiol Rev. 2013;26(3):462-475. 143. Xu ZQ, Broza YY, Ionsecu R, et al. A nanomaterial-based
doi: 10.1128/CMR.00020-13 breath test for distinguishing gastric cancer from benign
gastric conditions. Br J Cancer. 2013;108(4):941-950.
137. Dospinescu VM, Tiele A, Covington JA. Sniffing out urinary
tract infection-diagnosis based on volatile organic compounds doi: 10.1038/bjc.2013.44

Volume 3 Issue 2 (2024) 18 doi: 10.36922/td.2061